2020 Annual Results: SCOR absorbs the shock of Covid-19, recording a net income of EUR 234 million in 2020, and proposes a dividend of EUR 1.80 per share

Ads

You May Also Like

Coherus BioSciences Completes Patent Dance Exchange with Amgen for Neulasta Biosimilar

REDWOOD CITY, Calif., April 25, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), announced ...

Helsinn Group supports Satellite Symposium at EORTC CLTF 2018 Annual Meeting

Helsinn Group supports Satellite Symposium at EORTC CLTF 2018 Annual Meeting Lugano, Switzerland, September ...